Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Orphenadrine Citrate Extended-release Generic Name & Formulations
Legal Class
Rx
General Description
Orphenadrine citrate 100mg; sust-rel tabs.
Pharmacological Class
Anticholinergic.
See Also
How Supplied
Contact supplier
Manufacturer
Orphenadrine Citrate Extended-release Indications
Indications
Painful musculoskeletal conditions.
Orphenadrine Citrate Extended-release Dosage and Administration
Adult
100mg twice daily (AM and PM).
Children
Not recommended.
Orphenadrine Citrate Extended-release Contraindications
Contraindications
Glaucoma. Achalasia. GU or GI obstruction. Myasthenia gravis.
Orphenadrine Citrate Extended-release Boxed Warnings
Not Applicable
Orphenadrine Citrate Extended-release Warnings/Precautions
Warnings/Precautions
Coronary disease, insufficiency, or arrhythmias. Asthma (inj). Monitor blood, urine, and liver in long-term use. Pregnancy (Cat.C). Nursing mothers.
Orphenadrine Citrate Extended-release Pharmacokinetics
See Literature
Orphenadrine Citrate Extended-release Interactions
Interactions
Potentiates anticholinergics, alcohol, other CNS depressants, MAOIs, antidepressants. Tremors, mental confusion with propoxyphene. Antagonizes steroids, barbiturates, phenylbutazone.
Orphenadrine Citrate Extended-release Adverse Reactions
Adverse Reactions
Tachycardia, transient dizziness or syncope, other anticholinergic effects (eg, weakness, increased intraocular pressure, urinary retention, blurred vision, dry mouth), GI upset.
Orphenadrine Citrate Extended-release Clinical Trials
See Literature
Orphenadrine Citrate Extended-release Note
Notes
Formerly known under the brand name Norflex.
Orphenadrine Citrate Extended-release Patient Counseling
See Literature
